Citius Oncology (CTOR) director Jonathan Peri files Form 3 showing no common shares
Rhea-AI Filing Summary
CITIUS ONCOLOGY, INC. director Jonathan Peri filed an initial Form 3 reporting his equity position in the company. The filing lists a holding entry for Common Stock with 0 shares reported as directly owned following the reported position.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Peri Jonathan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Direct)
Key Figures
Common Stock directly owned: 0.0000 shares
Holding entries: 1
Net buy/sell shares: 0
3 metrics
Common Stock directly owned
0.0000 shares
Total shares following reported position
Holding entries
1
Number of holding entries in transaction summary
Net buy/sell shares
0
Net buy/sell direction reported as neutral
Key Terms
Common Stock, beneficial ownership, direct or indirect
3 terms
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
beneficial ownership financial
"initial statement of beneficial ownership of securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
direct or indirect financial
"direct_or_indirect: "D" indicates direct ownership type"
FAQ
What does Jonathan Peri’s Form 3 filing for CTOR report?
The Form 3 for CITIUS ONCOLOGY, INC. (CTOR) reports Jonathan Peri’s initial beneficial ownership, listing a holding entry in Common Stock with 0 shares directly owned following the reported position.
What position does Jonathan Peri hold at CITIUS ONCOLOGY, INC. (CTOR)?
The Form 3 indicates that Jonathan Peri is a director of CITIUS ONCOLOGY, INC. He is not reported as an officer or a ten percent owner in this filing.
Does the CTOR Form 3 for Jonathan Peri show any recent insider transactions?
No. The Form 3 presents a holding entry only, with no indicated purchase, sale, or other transaction codes. It simply establishes Jonathan Peri’s beneficial ownership position as of the reported date.
Are there any derivative securities reported for Jonathan Peri in the CTOR Form 3?
No derivative securities are listed. The derivativeSummary is empty and there are no derivative transactions reported, indicating only a common stock holding entry in this Form 3.
AI-generated analysis. How Rhea-AI works. Not financial advice.
